342 related articles for article (PubMed ID: 1096989)
1. Restoration of cell-mediated immune responses with transfer factor.
Kirkpatrick CH
Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
[TBL] [Abstract][Full Text] [Related]
2. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
Rocklin RE
Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
[TBL] [Abstract][Full Text] [Related]
3. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
4. Transfer factor II: results of therapy.
Spitler LE; Levin AS; Fudenberg HH
Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
[TBL] [Abstract][Full Text] [Related]
5. Transfer factor as an approach to the treatment of immune deficiency disease.
Schulkind ML; Ayoub EM
Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
[TBL] [Abstract][Full Text] [Related]
6. Transfer factor therapy in immuno-deficiencies.
Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
[No Abstract] [Full Text] [Related]
7. Transfer factor therapy in immunodeficiency.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
[No Abstract] [Full Text] [Related]
8. [Treatment of immunologic deficiency conditions by means of transfer factor].
Kobielowa Z
Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
[No Abstract] [Full Text] [Related]
9. Transfer factor therapy: evidence for nonspecificity.
Ballow M; Dupont B; Hansen JA; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
[TBL] [Abstract][Full Text] [Related]
10. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
12. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
[TBL] [Abstract][Full Text] [Related]
13. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
[No Abstract] [Full Text] [Related]
14. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
15. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
[TBL] [Abstract][Full Text] [Related]
16. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
[TBL] [Abstract][Full Text] [Related]
17. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
Mobacken H; Hanson LA; Lindholm L; Ljunggren C
Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
[TBL] [Abstract][Full Text] [Related]
18. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
[TBL] [Abstract][Full Text] [Related]
19. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
Elliott ST; Hanifin JM
Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.
Kirkpatrick CH; Ottenson EA; Smith TK; Wells SA; Burdick JF
Clin Exp Immunol; 1976 Mar; 23(3):414-28. PubMed ID: 947642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
